Quest PharmaTech Cash Flow Statement

Financials in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Net Income	5	-1.8	-3.02	-64.89	-85.04
Depreciation & Amortization	-	-	0	0.01	0.04
Stock-Based Compensation	0.08	0.08	0.47	0.15	0.27
Other Adjustments	-5.43	1.36	1.95	64.39	84.56
Changes in Accounts Payable	0.16	-0.15	0.22	-0	-
Changes in Other Operating Activities	0	-0	0.03	-0.22	-
Operating Cash Flow	-0.19	-0.51	-0.34	-0.55	-0.17
Other Investing Activities	-	-	-	-0.01	-0.01
Investing Cash Flow	-	-	-	-0.01	-0.01
Short-Term Debt Issued	-	-	0.2	0.5	0.25
Short-Term Debt Repaid	-	-	-0.2	-	-
Net Short-Term Debt Issued (Repaid)	-	-	0	0.5	0.25
Issuance of Common Stock	-	-	-	0.09	-
Net Common Stock Issued (Repurchased)	-	-	-	0.09	-
Other Financing Activities	-	-	0.68	0.09	-
Financing Cash Flow	-	-	0.68	0.68	0.25
Net Cash Flow	-0.19	-0.51	0.34	0.11	0.07
Free Cash Flow	-0.19	-0.51	-0.34	-0.55	-0.17
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
Levered Free Cash Flow	5.16	-1.96	-2.77	-64.6	-84.75
Unlevered Free Cash Flow	-0.55	-0.97	-1.06	-1.05	-0.75